Primecap Management CO Sio Gene Therapies Inc. Transaction History

Primecap Management CO

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	SELL	$0.28 - $0.44 $1,008 - $1,584	-3,600 Reduced 23.08%	12,000 $5,000
Q3 2022 Nov 14, 2022	SELL	$0.28 - $0.41 $308 - $451	-1,100 Reduced 6.59%	15,600 $4,000
Q2 2022 Aug 11, 2022	SELL	$0.25 - $0.73 $400 - $1,168	-1,600 Reduced 8.74%	16,700 $6,000
Q1 2022 May 11, 2022	SELL	$0.55 - $1.47 $990 - $2,646	-1,800 Reduced 8.96%	18,300 $12,000
Q4 2021 Feb 11, 2022	SELL	$1.29 - $2.36 $40,893 - $74,812	-31,700 Reduced 61.2%	20,100 $26,000
Q3 2021 Nov 12, 2021	SELL	$1.81 - $2.7 $950 - $1,417	-525 Reduced 1.0%	51,800 $112,000
Q1 2021 May 14, 2021	SELL	$2.34 - $3.44 $702 - $1,032	-300 Reduced 0.57%	52,325 $137,000
Q4 2020 Feb 08, 2021	BUY	$1.91 - $5.63 $100,513 - $296,278	52,625 New	52,625 $146,000

147K

Ticker SIOX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 73,975,200
Description
Sio Gene Therapies Inc., a clinical-stage company, focuses on developing gene therapies to radically transform the lives of patients with neurodegenerative diseases. It has a license agreement with Oxford BioMedica (UK) Ltd. to develop and commercialize AXO-Lenti-PD and related gene therapy products; and The University of Massachusetts Medical S...

Get notified when there are updates to the investment portfolio of Primecap Management CO, based on Form 13F filings with the SEC.

Stay updated on Primecap Management CO with notifications on news.